GPhA Battles State Biosimilar Bills; 5 Passed, 10 Rejected
Executive Summary
Generic Pharmaceutical Association wants to assure legislation on biologics substitution does not impose more restrictions than required for small molecules; opposes measures pushed by Amgen and Genentech.